KIF4B
Basic information
Region (hg38): 5:155013755-155018141
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KIF4B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 62 | 11 | 77 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 62 | 11 | 13 |
Variants in KIF4B
This is a list of pathogenic ClinVar variants found in the KIF4B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-155013912-C-T | not specified | Uncertain significance (Oct 20, 2023) | ||
5-155014083-G-T | not specified | Uncertain significance (Jul 20, 2021) | ||
5-155014116-C-A | not specified | Uncertain significance (Nov 14, 2023) | ||
5-155014236-T-C | not specified | Uncertain significance (May 01, 2024) | ||
5-155014329-A-G | not specified | Uncertain significance (Jul 05, 2023) | ||
5-155014334-G-C | not specified | Uncertain significance (Mar 16, 2024) | ||
5-155014404-T-C | KIF4B-related disorder | Uncertain significance (Jan 22, 2023) | ||
5-155014457-G-A | KIF4B-related disorder | Benign (Dec 20, 2019) | ||
5-155014466-A-G | not specified | Uncertain significance (Sep 27, 2021) | ||
5-155014491-G-A | not specified | Uncertain significance (Jan 10, 2022) | ||
5-155014517-A-G | KIF4B-related disorder | Benign (Oct 28, 2019) | ||
5-155014556-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
5-155014575-T-C | not specified | Uncertain significance (Mar 21, 2022) | ||
5-155014620-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
5-155014626-G-C | not specified | Uncertain significance (Jan 23, 2024) | ||
5-155014704-A-G | not specified | Uncertain significance (Aug 15, 2023) | ||
5-155014760-C-G | not specified | Uncertain significance (Sep 16, 2022) | ||
5-155014791-C-A | not specified | Uncertain significance (Jan 24, 2023) | ||
5-155014841-C-T | not specified | Uncertain significance (Apr 20, 2023) | ||
5-155014842-G-A | not specified | Uncertain significance (Nov 22, 2023) | ||
5-155014866-T-C | not specified | Uncertain significance (Jan 23, 2024) | ||
5-155015011-T-C | KIF4B-related disorder | Likely benign (Jul 12, 2019) | ||
5-155015017-A-G | KIF4B-related disorder | Benign (Apr 29, 2019) | ||
5-155015043-T-C | not specified | Uncertain significance (May 23, 2024) | ||
5-155015153-G-A | not specified | Uncertain significance (Mar 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KIF4B | protein_coding | protein_coding | ENST00000435029 | 1 | 4426 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.63e-25 | 0.000598 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.625 | 656 | 613 | 1.07 | 0.0000338 | 8179 |
Missense in Polyphen | 162 | 161.53 | 1.0029 | 2221 | ||
Synonymous | 0.113 | 233 | 235 | 0.991 | 0.0000127 | 2353 |
Loss of Function | 0.168 | 38 | 39.1 | 0.971 | 0.00000247 | 495 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Motor protein that translocates PRC1 to the plus ends of interdigitating spindle microtubules during the metaphase to anaphase transition, an essential step for the formation of an organized central spindle midzone and midbody and for successful cytokinesis. May play a role in mitotic chromosomal positioning and bipolar spindle stabilization (By similarity). {ECO:0000250}.;
- Pathway
- Developmental Biology;Recycling pathway of L1;Vesicle-mediated transport;Membrane Trafficking;Kinesins;Factors involved in megakaryocyte development and platelet production;Hemostasis;COPI-dependent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;L1CAM interactions;Axon guidance;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- 0.765
- rvis_EVS
- 1.14
- rvis_percentile_EVS
- 92.37
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.116
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- mitotic cytokinesis;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;microtubule-based movement;mitotic spindle organization;antigen processing and presentation of exogenous peptide antigen via MHC class II;mitotic spindle midzone assembly
- Cellular component
- nucleoplasm;cytosol;kinesin complex;microtubule;nuclear matrix;intercellular bridge
- Molecular function
- DNA binding;microtubule motor activity;ATP binding;microtubule binding;ATPase activity